2014
Withdrawal of Personal Genome Service—Reply
Downing NS, Ross JS. Withdrawal of Personal Genome Service—Reply. JAMA 2014, 311: 2441-2442. PMID: 24938574, DOI: 10.1001/jama.2014.5584.Commentaries, Editorials and LettersGenetic Predisposition to DiseaseGenetic TestingGovernment RegulationHumansMarketing of Health ServicesInnovation, Risk, and Patient Empowerment: The FDA-Mandated Withdrawal of 23andMe’s Personal Genome Service
Downing NS, Ross JS. Innovation, Risk, and Patient Empowerment: The FDA-Mandated Withdrawal of 23andMe’s Personal Genome Service. JAMA 2014, 311: 793-794. PMID: 24474248, DOI: 10.1001/jama.2014.148.Commentaries, Editorials and Letters
2013
Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis
King M, Essick C, Bearman P, Ross JS. Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis. The BMJ 2013, 346: f264. PMID: 23372175, PMCID: PMC3623604, DOI: 10.1136/bmj.f264.Peer-Reviewed Original ResearchMeSH KeywordsAntidepressive AgentsAntipsychotic AgentsCase-Control StudiesCentral Nervous System StimulantsCyclohexanolsDesvenlafaxine SuccinateDextroamphetamineDrug IndustryGift GivingHealth Care SectorHumansInterprofessional RelationsIsoxazolesMarketing of Health ServicesOrganizational PolicyPaliperidone PalmitatePractice Patterns, Physicians'Psychotropic DrugsPyrimidinesSchools, MedicalUnited StatesConceptsPsychotropic medicationsSubsequent prescribing behaviorPhysician prescribingPsychotropic classesOlder antipsychoticsPrescribing behaviorMAIN OUTCOMEMedicationsMedical schoolsPrescribingPhysiciansAntipsychoticsRestriction policiesDesvenlafaxinePaliperidoneStimulantsUS medical schoolsExposureLonger exposureAntidepressantsCohort